Trial · NCT06118619
A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis
NCT06118619, Unknown, SPP Pharmaclon Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis. Trials, record NCT06118619. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06118619
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis
- NCT number
- NCT06118619
- Status
- Unknown
- Enrollment
- 350 participants, estimated
- Lead sponsor
- SPP Pharmaclon Ltd.
- Conditions
- Respiratory Tuberculosis
- Interventions
- Interferon-Gamma
- First posted
- 2023-11-07
- Last updated
- 2023-11-09
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of abacillated patients | 1 month | Proportion of abacillated patients according to fluorescence microscopy |
| Primary | Proportion of abacillated patients | 1 month | Proportion of abacillated patients according to culture data |
| Primary | Proportion of abacillated patients | 2 month | Proportion of abacillated patients according to fluorescence microscopy |
| Primary | Proportion of abacillated patients | 2 month | Proportion of abacillated patients according to culture data |
| Secondary | Proportion of patients who died | 5 month | deaths associated with HIV infection and/or tuberculosis |
| Secondary | Proportion of patients who required a change in therapy | 5 month | Proportion of patients who required a change in therapy due to ineffectiveness |
| Secondary | Proportion of patients with adverse reactions | 5 month | Proportion of patients with adverse reactions, including those who required changes in therapy due to intolerance |
| Secondary | Changes in the level of CD4 lymphocytes and HIV viral load in the blood | 5 month | Changes in the level of CD4 lymphocytes and HIV viral load in the blood (Proportion of patients with a CD4 level less than 350 cells/ml) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 39871554 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06118619
GET https://conductscience.org/api/trials/v1/NCT06118619/registered